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Abstract
It has been shown that erythrocyte membrane proteins become susceptible to degradation by membrane-bound serine
protease activity after oxidative modification of the membranes (M. Beppu, M. Inoue, T. Ishikawa, K. Kikugawa, Biochim.
Biophys. Acta 1196 (1994) 81^87). The aim of the present study was to clarify the presence of the serine protease in oxidized
erythrocyte membranes and to characterize the selectivity of the enzyme to oxidized proteins. Human erythrocytes were
oxidized in vitro with xanthine/xanthine oxidase/Fe(III) and oxidized membranes isolated. Proteolytic activity of the
membranes toward spectrin obtained from oxidized membranes and bovine serum albumin oxidized with H2O2/horseradish
peroxidase was increased by membrane oxidation, and the degradability of the substrates was increased by substrate
oxidation. The proteolytic activity was inhibited by the serine protease inhibitor diisopropyl fluorophosphate (DFP). The
72 kDa and 80 kDa proteins in the membranes were labeled by [3H]DFP when detected by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis under reducing conditions and subsequent fluorography. The 72 kDa protein was found
to be a serine enzyme, acetylcholine esterase. The 80 kDa protein appeared to be responsible for the degradation of
oxidatively damaged proteins. The 80 kDa protein was loosely bound to membranes and readily solubilized into a 0.1%
NP-40 detergent solution. The presence of the same 80 kDa protease in intact erythrocyte cytosol was suggested. The
increased serine protease activity in oxidized membranes can result from the increased adherence of the cytosolic 80 kDa
serine protease to the membranes due to oxidation. 0005-2736 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All
rights reserved.
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1. Introduction
The presence of ATP-independent, and therefore
ubiquitin-independent proteases in erythrocyte and
reticulocyte extracts [1^8], mitochondria [9,10] and
Escherichia coli extracts [5,11^13] that are speci¢c
to oxidatively damaged intracellular proteins has
been demonstrated. A multicatalytic proteolytic com-
plex composed of several subunits has been shown to
be responsible for the degradation of the oxidized
intracellular proteins in erythrocytes and reticulo-
cytes [6^8]. These proteases have been referred to
as the secondary antioxidant defense system of the
cells [14].
It has been shown in our previous study that
erythrocyte membrane proteins become susceptible
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to degradation by membrane-bound serine protease
activity after oxidative modi¢cation of the mem-
branes [15]. This suggested the presence of secondary
antioxidant defense mechanisms in erythrocyte mem-
branes for the removal of the oxidatively damaged
membrane proteins by proteases. The protease in
erythrocyte membranes responsible for degradation
of oxidatively damaged proteins appears to be di¡er-
ent from the multicatalytic proteases previously
demonstrated [6^8] because the e¡ect of various pro-
tease inhibitors on protein degradation was di¡erent
between the two systems [15]. The aim of the present
study is to clarify the presence of the serine protease
in oxidized erythrocyte membranes and to character-
ize the speci¢city of the protease to oxidized proteins.
It was found that an 80 kDa serine protease is
present in erythrocyte membrane that preferentially
degrades oxidized proteins. This enzyme may origi-
nate in erythrocyte cytosol and become adherent to
membranes when the cells are oxidized.
2. Materials and methods
2.1. Materials
Xanthine (X), xanthine oxidase (XO) (EC 1.1.3.22)
(from buttermilk, grade III, diisopropyl £uorophos-
phate (DFP), phenylmethylsulfonyl £uoride (PMSF),
Nonidet P-40 (NP-40), bovine serum albumin (BSA)
(fatty acid free) and horseradish peroxidase (HRP)
(EC 1.11.1.7) were obtained from Sigma (St. Louis,
MO, USA). XO was treated as follows [15]. A solu-
tion of XO (50 U/2.4 ml) was diluted at an enzyme
concentration of 2 U/ml with a bu¡er composed of
25 mM potassium dihydrogen phosphate, 125 mM
choline chloride, 0.01 mM ethylenediaminetetraacetic
acid (EDTA) and 2.5 mM sodium azide (pH 7.4). To
1 ml of the solution 5 Wl of 0.2 M DFP solution in
ethanol and 2 Wl of 0.2 M PMSF solution in ethanol
were added, and the mixture was allowed to stand at
4‡C for 12 h to inactivate the contaminating pro-
teases [16]. After the mixture was dialyzed against
the same bu¡er, it was stored at 380‡C until use.
125I-Bolton-Hunter reagent (N-succinimidyl-3-(4-
hydroxy-3-[125I]iodophenyl)propionate; 2335 Ci/
mmol), [1,3-3H]DFP ([3H]DFP; 6.0 Ci/mmol),
EN3HANCE and Aquasol-2 for 3H measurement
were obtained from NEN Research Products (Bos-
ton, MA, USA).
Human venous blood withdrawn from a healthy
donor using acid-citrate-dextrose as an anticoagulant
was stored at 4‡C for a couple of days. Blood was
centrifuged (320Ug, 10 min) at 4‡C to remove plas-
ma and bu¡y coats. Erythrocyte pellet was washed
four times by centrifugation (320Ug, 10 min) at 4‡C
with ice-cold Ca2ÿ, Mg2-free Dulbecco’s phos-
phate-bu¡ered saline (pH 7.4) (DPBS(3)). By this
procedure, erythrocyte preparations with only about
1/18 000 leukocyte contamination as determined by
crystal violet staining were obtained.
2.2. Analysis
Proteins in the membrane preparations were deter-
mined by the method of Lowry et al. [17] using BSA
as a reference standard. Hemoglobin content in
erythrocyte cytosol was determined by absorbance
at 523 nm and its molar extinction coe⁄cient of
7880 [16]. Sodium dodecyl sulfate (SDS)-polyacryla-
mide gel electrophoresis (PAGE) was performed ac-
cording to the method of Laemmli [18] in a discon-
tinuous bu¡er system with a 7.5 or 10% separating
gel and a 4% stacking gel under reducing conditions.
The samples containing 25 Wg protein were loaded
per lane unless otherwise speci¢ed. Protein bands
after SDS-PAGE were stained by Coomassie brilliant
blue R-250. For £uorography of [3H]DFP-labeled
proteins, the gel of SDS-PAGE was rinsed in 10%
acetic acid for 1^2 h to ¢x proteins in the gel. After
removal of acetic acid, the gel was shaken in
EN3HANCE for 1 h. After removal of EN3HANCE,
the gel was shaken in ice-cold water for 1 h. After
drying the gel, the radioactivity of the gel was visual-
ized using a Kodak XAR-5 X-ray ¢lm with the aid
of a lightning plus (Dupont de Nemours, Wilming-
ton, DE, USA) at 380‡C.
3H- and 125I-radioactivities were counted using an
Aloka LSC 3500 liquid scintillation counter (Tokyo,
Japan) and an Aloka ARC 2000 autowell Q-ray coun-
ter (Tokyo, Japan), respectively.
2.3. Oxidation of erythrocytes
Oxidation of erythrocytes was performed as de-
scribed previously [15]. To 100 ml of 40% erythrocyte
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suspension in DPBS(3), 100 ml of 2 mM X in
Dulbecco’s phosphate-bu¡ered saline (pH 7.4)
(DPBS(+)), 1.0 ml of 2 U/ml XO solution and
2.0 ml of 10 mM FeCl3 solution in 40 mM HCl
were added. The DPBS(+) has su⁄cient bu¡er ca-
pacity to maintain the pH of the suspension. The
suspension was incubated at 37‡C for 3 h under aero-
bic conditions. Oxidized erythrocytes were recovered
by centrifugation at 320Ug at 4‡C for 10 min and
washed twice with DPBS(+) by centrifugation. Un-
oxidized control erythrocytes were obtained by the
same incubation conditions without the oxidants.
2.4. Preparation of erythrocyte membranes and
cytosol
Erythrocyte pellet was lysed in 40 vols. of 5 mM
sodium phosphate bu¡er (pH 8.0). The lysate was
centrifuged at 9600Ug for 20 min to obtain erythro-
cyte membrane pellet. The membrane pellet was
washed several times with the bu¡er by centrifuga-
tion until the supernatant became colorless. The
membrane pellets from oxidized and unoxidized con-
trol erythrocytes were resuspended in DPBS(+) con-
taining 0.1 mM K-tocopherol, and the membrane
pellet from intact erythrocytes was resuspended in
DPBS(3). All the operations were performed at
4‡C. The membrane suspension was stored at
380‡C until use.
Erythrocyte cytosol was prepared according to the
method previously reported [5]. A preparation of in-
tact erythrocyte pellet was lysed in 1.5 vols. of 1 mM
dithiothreitol for 1 h. The mixture was centrifuged at
10 000Ug for 20 min to obtain the supernatant,
which was then centrifuged at 18 500Ug for 60
min. The supernatant was dialyzed against 10 mM
Tris-HCl bu¡er (pH 7.8) containing 5 mM MgCl2,
0.5 mM dithiothreitol, 8 mM KCl and 10% glycerol
to obtain erythrocyte cytosol. The cytosol prepara-
tion was stored at 380‡C until use.
2.5. Preparation of oxidized and unoxidized spectrin
and 125I-radiolabeling
Oxidized or unoxidized spectrin from oxidized or
unoxidized erythrocytes was prepared by the method
previously described [19]. Erythrocyte membrane was
prepared from 400 ml of oxidized or unoxidized
erythrocytes according to the method of Dodge et
al. [20]. The membrane preparation was suspended
in 1000 ml solution (pH 7.5) containing 1 mM
EDTA, 5 mM 2-mercaptoethanol and 0.03 mM
PMSF, and spectrin was extracted by standing the
solution for 18 h. The suspension was centrifuged at
100 000Ug for 1 h to obtain spectrin extract. To the
extract sodium azide at 0.02% was added, and the
extract was condensed using an Amicon membrane
¢lter (PM 30) and equilibrated with 10 mM Tris-HCl
bu¡er (pH 8.0) containing 20 mM sodium chloride,
130 mM potassium chloride, 0.1 mM EDTA, 0.5
mM 2-mercaptoethanol and 0.03 mM PMSF. The
solution was passed through a column (2.5U90 cm)
of Sepharose CL-4B. A 280 nm absorbing fraction
corresponding to spectrin dimer was collected and
condensed to obtain spectrin preparation. The prep-
aration was dialyzed against 10 mM sodium phos-
phate bu¡er (pH 8.0).
125I-Labeling of spectrin was carried out by the
method of Bolton and Hunter [21]. A 150 Wl solution
of 100 Wg spectrin and 250 WCi 125I-Bolton-Hunter
reagent were mixed, and the mixture was kept at 4‡C
overnight under stirring. To stop the reaction 50 Wl
of 50 mM phosphate bu¡er (pH 7.5) containing
10 mg/ml glycine were added, and the mixture stirred
at 4‡C for 1 h. The mixture was applied to a column
of Sephadex G-50 and the column eluted with
DPBS(3) containing 0.02% sodium azide to obtain
125I-oxidized or unoxidized spectrin. Speci¢c activity
of 125I-oxidized and unoxidized spectrin was 1.2U105
and 2.26U105 cpm/Wg protein, respectively. The
preparations were stored at 4‡C.
2.6. Preparation of oxidized and unoxidized BSA and
125I-radiolabeling
A mixture of 10 ml of a solution of BSA at 0.5 mg/
ml in 50 mM Tris-HCl (pH 7.8), 1.0 ml of 0.2 M
H2O2 in the same bu¡er and 0.1 ml of a solution of
HRP at 0.1 mg/ml in the same bu¡er was incubated
at 37‡C for 20 h. The mixture was then dialyzed
against 10 mM sodium phosphate bu¡er (pH 8.0)
to obtain oxidized BSA. BSA was similarly treated
without the oxidant to obtain unoxidized BSA.
125I-Labeling of BSA was carried out as described
for that of spectrin using a 200 Wl solution of 70 Wg
BSA and 250 WCi 125I-Bolton-Hunter reagent. Spe-
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ci¢c activity of 125I-oxidized and unoxidized BSA
obtained was 0.77U106 and 2.6U106 cpm/Wg pro-
tein, respectively. The 125I-oxidized and unoxidized
BSA preparations were mixed with unlabeled oxi-
dized and unoxidized BSA, respectively, to reduce
their speci¢c radioactivity to 1/10. The preparations
were stored at 4‡C.
2.7. Degradation of 125I-oxidized and unoxidized
spectrin by oxidized and unoxidized erythrocyte
membranes
A mixture of 20 Wl of 125I-oxidized or unoxidized
spectrin (0.1 Wg protein) solution in DPBS(3) and
100 Wl of oxidized or unoxidized erythrocyte mem-
brane suspension (25 Wg protein) in DPBS(+) was
incubated at 37‡C for the indicated period. To the
mixture were added 380 Wl of a solution of BSA at
1 mg/ml as a carrier protein. To the mixture were
added 500 Wl of cooled 20% trichloroacetic acid,
and the mixture was cooled on ice for 1 h. Radio-
activity of the whole mixture was counted. After cen-
trifugation at 320Ug for 10 min, trichloroacetic acid-
soluble radioactivity of the 500 Wl of the supernatant
was counted. Radioactivities without added erythro-
cyte membrane suspensions were subtracted.
2.8. Degradation of 125I-oxidized and unoxidized BSA
by intact, unoxidized and oxidized erythrocyte
membranes and intact erythrocyte cytosol
A mixture of 100 Wl of erythrocyte membrane sus-
pension (200 Wg protein) in 0.1% NP-40/DPBS(+)
and 5 Wl of 125I-oxidized or unoxidized BSA (0.1
Wg) solution in 10 mM sodium phosphate bu¡er
(pH 8.0) was incubated at 37‡C for the indicated
period. To the mixture were added 395 Wl of a solu-
tion of BSA at 1 mg/ml as a carrier protein. For
investigation of the e¡ect of DFP, 1 Wl of a solution
of 0.2 M DFP was added to 100 Wl of the erythrocyte
membrane suspension. To the mixture were added
500 Wl of cooled 20% trichloroacetic acid, and the
mixture was cooled on ice for 1 h. Radioactivity of
the whole mixture was counted. After centrifugation
at 8000Ug for 10 min, trichloroacetic acid-soluble
radioactivity of 500 Wl of the supernatant was
counted. Radioactivities without added erythrocyte
membrane suspensions were subtracted.
A mixture of 100 Wl of erythrocyte cytosol (16.8
mg hemoglobin) and 5 Wl of 125I-oxidized or un-
oxidized BSA (0.1 Wg) solution in 10 mM sodium
phosphate bu¡er (pH 8.0) was incubated at 37‡C
for 48 h. The mixture was similarly treated as
described above.
2.9. [3H]DFP-labeling of intact erythrocyte
membranes and cytosol
To 20 ml of intact erythrocyte membrane suspen-
sion (100 mg protein) in DPBS(3), 100 Wl of a solu-
tion of 1 mCi/ml (0.1 Wmol/ml) [3H]DFP in propy-
lene glycol was added, and the mixture stirred at
room temperature for 3 h. Unlabeled DFP was
then added at a ¢nal concentration of 2 mM, and
the mixture kept at 4‡C for 15 h. The mixture was
dialyzed against 1 mM EDTA. Speci¢c activity of
[3H]DFP-labeled intact erythrocyte membranes was
27 600 cpm/mg protein. The labeled preparation was
stored at 380‡C until use.
For investigation of the e¡ect of butyrylcholine
iodide on [3H]DFP-labeling of intact erythrocyte
membranes, a mixture of 500 Wl of intact erythrocyte
membrane suspension (1.5 mg protein) in DPBS(3)
and 500 Wl of a solution of 5 M butyrylcholine iodide
in DPBS(3) was cooled on ice for 30 min. To the
mixture 5 Wl of 1 mCi/ml (0.1 Wmol/ml) [3H]DFP in
propylene glycol was added, and the mixture stirred
at room temperature for 1 h. Unlabeled DFP was
then added at a ¢nal concentration of 2 mM, and
the mixture kept at room temperature for 30 min.
The mixture was centrifuged at 16 000Ug for 40
min at 4‡C, and the membranes were washed once
with DPBS(3) containing 0.25 M butyrylcholine io-
dide by centrifugation to be resuspended in the same
bu¡er to make a total volume of 1.0 ml. The suspen-
sion was dialyzed against water.
To 200 Wl of erythrocyte cytosol (3.4 mg hemoglo-
bin) 20 Wl of a solution of 1 mCi/ml (0.1 Wmol/ml)
[3H]DFP were added, and the mixture was stirred at
room temperature for 3 h. The mixture was treated
as described above. Speci¢c activity of [3H]DFP-la-
beled intact erythrocyte cytosol was 34 400 cpm/mg
hemoglobin. The labeled preparation was stored at
380‡C until use.
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2.10. Solubilization of intact erythrocyte membranes
in 0.1% NP-40
To 15 ml of intact erythrocyte membrane suspen-
sion (75 mg protein), 15 ml of 100 mM Tris-HCl
bu¡er (pH 8.0) containing 0.2 M NaCl, 2 mM
EDTA and 0.2% NP-40 were added, and the mixture
was stirred at 37‡C for 1 h. The mixture was then
centrifuged at 15 000Ug and 4‡C for 20 min to ob-
tain the solubilized supernatant and the residue.
2.11. Gel ¢ltration of intact erythrocyte membranes
solubilized in 0.1% NP-40
To 2.0 ml of [3H]DFP-labeled intact erythrocyte
membranes solubilized in 0.1% NP-40 (1.6U105
cpm/3.1 mg protein), 8.0 ml of intact erythrocyte
membranes solubilized in 0.1% NP-40 (18.6 mg pro-
tein) were added. The mixture was applied to a col-
umn (2.5 cm i.d.U130 cm) of Sepharose CL-6B equi-
librated with 50 mM Tris-HCl (pH 8.0) containing
0.1 M NaCl, 1 mM EDTA and 0.1% NP-40. The
column was eluted with the same bu¡er at 4‡C at a
£ow rate of 0.5 ml/min. The fractions were moni-
tored by radioactivity and protein. The fractions
were condensed using an Amicon membrane ¢lter
(PM 10).
3. Results
It has been shown that erythrocyte membrane pro-
teins become susceptible to degradation by mem-
brane-bound serine protease activity after oxidative
modi¢cation of the membranes [15]. At that time it
was not clear whether the increased susceptibility due
to oxidative stress re£ected the increased proteolytic
activity of enzymes or the increased degradability of
oxidized proteins. To clarify these two possibilities,
the following experiments were performed. Human
erythrocytes were not treated (unoxidized) or oxi-
dized with X/XO/Fe(III) at 37‡C for 3 h. Erythrocyte
membranes and spectrin were prepared from the un-
oxidized and the oxidized erythrocytes. Unoxidized
and oxidized spectrin were radioiodinated with 125I-
Bolton-Hunter reagent, and incubated at 37‡C for up
to 12 h with the unoxidized and oxidized erythrocyte
membrane suspensions. Degradation of 125I-spectrin
was examined by the release of trichloroacetic acid-
soluble radioactivity (Fig. 1). While the extent of
degradation of unoxidized spectrin in incubation
Fig. 1. Degradation of 125I-unoxidized and oxidized spectrin by
unoxidized and oxidized erythrocyte membranes. Unoxidized
and oxidized spectrin obtained from erythrocytes treated with-
out (a) or with X/XO/Fe(III) at 1 mM/10 mU ml31/0.1 mM
(b) at 37‡C for 3 h were labeled with 125I and incubated at
37‡C for the indicated period with erythrocyte membrane sus-
pension obtained from erythrocytes treated without (- - -) or
with the oxidant (9999) at 37‡C for 3 h. Degradation of
125I-spectrin was examined by the release of trichloroacetic
acid-soluble radioactivity. The data are the means of duplicate
experiments.
Fig. 2. Degradation of 125I-unoxidized and oxidized BSA by
unoxidized and oxidized erythrocyte membranes. Unoxidized
and oxidized BSA obtained from BSA treated without (a) or
with H2O2/HRP at 20 mM/1 Wg ml31 (b) at 37‡C for 20 h
were labeled with 125I and incubated at 37‡C for the indicated
period with erythrocyte membrane suspension in 0.1% NP-40/
DPBS(+) obtained from erythrocytes treated without (- - -) or
with X/XO/Fe(III) at 1 mM/10 mU ml31/0.1 mM (9999) at
37‡C for 3 h. Degradation of 125I-BSA was examined by the re-
lease of trichloroacetic acid-soluble radioactivity. The data are
the means of duplicate experiments.
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with unoxidized membranes was small (open circle,
dotted line), the extent was larger in incubation with
oxidized membranes (open circle, solid line). How-
ever, the extent of degradation of unoxidized spectrin
by oxidized membranes was moderate as well as the
extent of degradation of oxidized spectrin by unoxi-
dized membranes (closed circle, dotted line). The ex-
tent of degradation of oxidized spectrin by oxidized
membranes (closed circle, solid line) was the highest.
It is likely that both proteolytic activity of the mem-
branes and degradability of the substrate were in-
creased by membrane oxidation.
Protein degradation by oxidized erythrocyte mem-
branes was examined using BSA oxidized with H2O2/
HRP. 125I-Radiolabeled unoxidized and oxidized
BSA were incubated at 37‡C for up to 48 h with a
suspension of unoxidized or oxidized erythrocyte
membranes in 0.1% NP-40 (Fig. 2). While the extent
of degradation of unoxidized BSA in incubation with
unoxidized membranes was small (open circle, dotted
line), the extent was slightly larger in incubation with
oxidized membranes (open circle, solid line). The ex-
tent of degradation of unoxidized BSA by oxidized
membranes was moderate as well as the extent of
degradation of oxidized BSA by unoxidized mem-
branes (closed circle, dotted line). The extent of deg-
radation of oxidized BSA by oxidized membranes
(closed circle, solid line) was the highest. The results
are consistent with the results of Fig. 1, showing that
both proteolytic activity in the membranes and de-
gradability of the substrate were increased by oxida-
tion.
It has been shown previously that a serine protease
inhibitor DFP strongly and a metalloprotease inhib-
itor EDTA slightly suppressed the degradation of
proteins of oxidized erythrocyte membranes [15]. In-
hibitory activity of DFP and EDTA in the degrada-
tion of unoxidized or oxidized BSA by erythrocyte
membranes in 0.1% NP-40 was examined. The results
are shown in Table 1. Unoxidized, oxidized, and in-
tact membranes degraded oxidized BSA more e⁄-
ciently than unoxidized BSA. While DFP only
slightly inhibited the degradation of unoxidized
BSA, it e¡ectively inhibited the degradation of oxi-
dized BSA. However, the degree of inhibition by
DFP of oxidized BSA degradation was not complete,
and the levels of degradation in the presence of the
inhibitor were close to the level of unoxidized BSA
degradation in the absence or presence of the inhib-
itor. Hence the increased protein degradation ob-
served for oxidized BSA is likely to be caused by a
serine protease, and the protein degradation uninhi-
bitable by DFP, which is also observed for unoxi-
dized BSA, may be caused by proteases of other
types. The results suggest that the membrane serine
protease preferentially degrades oxidized protein.
EDTA (5 mM) did not inhibit BSA degradation in
any combination of BSA and membrane prepara-
tions (data not shown), indicating that metallopro-
teases in the membrane did not contribute to the
degradation of oxidized protein.
In order to characterize the serine protease in
erythrocyte membranes, proteins that could be la-
beled with [3H]DFP were pursued. Intact, unoxidized
or oxidized erythrocyte membranes were incubated
with [3H]DFP at room temperature for 3 h to obtain
[3H]DFP-labeled membranes. The labeled mem-
branes from intact erythrocytes were solubilized in
0.1% NP-40, and 56% of the radioactivity and 31%
of protein were recovered in the solubilized super-
natant. [3H]DFP-labeled intact erythrocyte mem-
branes, their 0.1% NP-40-solubilized fraction and
the 0.1% NP-40-residual fraction were analyzed on
SDS-PAGE under reducing conditions (Fig. 3A) and
subsequent £uorography (Fig. 3B). Two radioactive
protein bands at 72 and 80 kDa were detected by
£uorography. Radioactivity at 72 and 80 kDa pro-
Table 1
Degradation of 125I-unoxidized and oxidized BSA by erythro-
cyte membranes and cytosol and its inhibition by DFP
Preparation from
erythrocyte
125I-BSA degradation (% of total
BSA)
Unoxidized BSA Oxidized BSA
3DFP +DFP 3DFP +DFP
Unoxidized membranes 6.3 6.1 10.4 4.8
Oxidized membranes 8.0 6.9 14.1 5.1
Intact membranes* 8.7 7.8 24.1 5.4
Intact cytosol 2.6 1.7 7.5 5.7
Unoxidized and oxidized BSA obtained from BSA treated with-
out or with H2O2/HRP at 20 mM/1 Wg ml31 at 37‡C for 20 h
were labeled with 125I and incubated at 37‡C for 96 h with
erythrocyte membrane suspension or its supernatant (*) in 0.1%
NP-40/DPBS(+), or at 37‡C for 48 h with erythrocyte cytosol
in the absence or the presence of 2 mM DFP. Degradation of
BSA was examined by the release of trichloroacetic acid-soluble
radioactivity. The data are the means of duplicate experiments.
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tein bands was detected in the labeled membranes
and their 0.1% NP-40-solubilized fraction, but radio-
activity at the 80 kDa protein band did not appear in
the 0.1% NP-40-residual fraction. The result indi-
cates that 80 kDa protein was loosely bound to the
membranes and readily solubilized by 0.1% NP-40.
SDS-PAGE and subsequent £uorography of both
[3H]DFP-labeled unoxidized and oxidized erythro-
cyte membranes revealed both the radioactive pro-
tein bands at 72 and 80 kDa (data not shown).
It has been known that acetylcholine esterase, a
serine enzyme, is present in human erythrocyte mem-
branes, which is labeled by [3H]DFP at a 72 kDa
band on SDS-PAGE [22] and exists as multiform
aggregates in 0.1% Triton X-100 [23]. Butyrylcholine
iodide is known to block the active center of acetyl-
choline esterase and thus inhibit the labeling by
[3H]DFP [24]. [3H]DFP-labeling of 72 kDa protein
was completely inhibited by preincubation with bu-
tyrylcholine iodide, but the labeling of 80 kDa pro-
tein was not (Fig. 4). Hence, the 72 kDa protein was
identi¢ed as acetylcholine esterase. The 80 kDa pro-
tein is most likely to be serine protease responsible
for the degradation of oxidatively damaged proteins.
To isolate 80 kDa protein in membrane, [3H]DFP-
labeled intact erythrocyte membrane solution in 0.1%
NP-40 mixed with unlabeled intact membrane solu-
tion was passed through a column of Sepharose CL-
6B in the presence of 0.1% NP-40. Radioactivity and
protein of each fraction were monitored (Fig. 5), and
three radioactive peaks F I (molecular mass near to
4000 kDa), F II (molecular mass slightly above 67
kDa) and F III were obtained. High-molecular-
weight F I and F II fractions were condensed by
ultra¢ltration and analyzed by SDS-PAGE and sub-
sequent £uorography (Fig. 6). It was found that F I
contained 72 kDa protein and F II contained 80 kDa
protein. In the absence of SDS, 72 kDa protein must
have been aggregated [23] and eluted in F I, a peak
fraction with a higher molecular weight. By contrast,
80 kDa protein appears to exist as a monomer in
0.1% NP-40 and eluted in F II.
The presence of 80 kDa protein in cytosol of intact
erythrocytes was investigated because it was readily
solubilized from membranes into 0.1% NP-40. Intact
erythrocyte cytosol was labeled with [3H]DFP, and
Fig. 4. SDS-PAGE and subsequent £uorography of [3H]DFP-
labeled intact erythrocyte membrane suspension in the absence
(a) and the presence of butyrylcholine iodide (b). Loaded radio-
activity: lane a, 700 cpm/lane, lane b, 3000 cpm/lane.
Fig. 3. SDS-PAGE (A) and subsequent £uorography (B) of
[3H]DFP-labeled intact erythrocyte membrane suspension (a),
0.1% NP-40-solubilized fraction of intact erythrocyte mem-
branes (b), and 0.1% NP-40 residue of intact erythrocyte mem-
branes (c). Protein bands in A were stained with Coomassie
brilliant blue R-250.
Fig. 5. Gel ¢ltration of [3H]DFP-labeled intact erythrocyte
membranes through Sepharose CL-60. [3H]DFP-labeled intact
erythrocyte membranes solubilized in 0.1% NP-40 were mixed
with unlabeled intact erythrocyte membranes solubilized in
0.1% NP-40. The mixture was applied to a column (2.5 cm
i.d.U130 cm) of Sepharose CL-6B equilibrated with 50 mM
Tris-HCl (pH 8.0) containing 0.1 M NaCl, 1 mM EDTA and
0.1% NP-40. The column was eluted with the same bu¡er at
4‡C at a £ow rate of 0.5 ml/min.
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subjected to SDS-PAGE and subsequent £uorogra-
phy. A single radioactive band at 80 kDa was ob-
servable (Fig. 7), suggesting that the same protein
was present in intact erythrocyte cytosol. Proteolytic
activities of cytosol toward 125I-labeled unoxidized
and oxidized BSA in the absence and presence of
DFP were compared (Table 1, lower section). It
was found that oxidized BSA was a better substrate
and degradation was partially inhibited by DFP.
Hence, the 80 kDa serine protease in oxidized eryth-
rocyte membranes may be derived from erythrocyte
cytosol.
4. Discussion
It has been shown in our previous study that er-
ythrocyte membrane proteins become susceptible to
degradation by membrane-bound serine protease ac-
tivity after oxidative modi¢cation of the membranes
[15]. In the present study, the presence of a serine
protease responsible for preferential degradation of
oxidatively damaged proteins was elucidated. It was
found that the molecular mass of the serine protease
is 80 kDa and the protease is loosely bound to the
oxidized membranes. The protease in the oxidized
membrane may be derived from erythrocyte cytosol.
Proteolytic activity of membranes from unoxidized
and oxidized erythrocytes against unoxidized and
oxidized spectrin, and against unoxidized and oxi-
dized BSA was compared. Both proteolytic activity
in the membranes and degradability of the substrates
were increased, respectively, by membrane oxidation
and substrate oxidation. Increase in the degradability
of the substrates by oxidation may be due to the
increased hydrophobic nature of the substrates, be-
cause it is known that hydrophobicity of proteins
increases by oxidation [25^28]. Oxidation of proteins
causes exposure of hydrophobic residues of the pro-
teins to the surface of the molecules [27,28]. It is
conceivable that the protease may preferentially hy-
drolyze the surface hydrophobic residues of the oxi-
datively modi¢ed protein molecules.
The proteolytic activity of the membranes toward
oxidized proteins was inhibited by a serine protease
inhibitor DFP, and two proteins in the membranes
were radiolabeled with [3H]DFP: 72 kDa (near to
4000 kDa on gel ¢ltration) and 80 kDa (slightly larg-
er than 67 kDa on gel ¢ltration) proteins on analysis
by SDS-PAGE under reducing conditions and sub-
sequent £uorography. In erythrocyte membranes, the
presence of several proteases including calpain [29],
cathepsin E [30,31], acid proteinase [32] and multi-
catalytic proteinase [33] has been known. On the
other hand, in erythrocyte cytosol proteases selective
to oxidized hemoglobin or oxidized proteins are
known [6,7]. Erythrocyte cytosolic proteases hitherto
known show 670 kDa (on gel ¢ltration) and 21.5^
35.7 kDa protein (on SDS-PAGE under reducing
conditions) or 700 kDa (on gel ¢ltration) [6] and
23^32 kDa protein (on SDS-PAGE under reducing
conditions) [7]. The 72 and 80 kDa proteins in the
Fig. 7. Fluorography after SDS-PAGE of [3H]DFP-labeled in-
tact erythrocyte membranes (a) and cytosol (b).
Fig. 6. SDS-PAGE (A) and subsequent £uorography (B) of gel
fractions F I (b) and F II (c) from [3H]DFP-labeled intact
erythrocyte membranes (a) obtained in Fig. 5. Protein bands in
A were stained with Coomassie brilliant blue R-250.
BBAMEM 77449 9-9-98
T. Fujino et al. / Biochimica et Biophysica Acta 1374 (1998) 47^5554
present study were di¡erent from these proteases
with respect to DFP susceptibility and molecular
weight. Acetylcholine esterase, a serine enzyme, is
known to be present in erythrocyte membrane [22^
24]. It was found that the 72 kDa protein in the
present study was acetylcholine esterase, because
the molecular weight of the enzyme was similar to
that of acetylcholine esterase and [3H]DFP-labeling
was inhibited by a speci¢c inhibitor of acetylcholine
esterase butyrylcholine iodide [24]. To our knowl-
edge, the presence of the 80 kDa serine protease in
erythrocyte membranes has not been hitherto known.
This serine protease may preferentially degrade oxi-
datively modi¢ed membrane proteins.
The 80 kDa serine protease was loosely bound to
erythrocyte membranes and could be released readily
in a weak detergent NP-40. The proteolytic activity
of membranes may have been increased by attach-
ment of the enzyme present in cytosol to membranes
when the cells were oxidized. The ¢nding that the
protein with the same molecular weight and enzyme
activity was present in intact erythrocyte cytosol sup-
ports this hypothesis.
The 80 kDa serine protease may be present origi-
nally in erythrocyte cytosol, and when erythrocyte
membranes become oxidized, the protease may ad-
here to the oxidized membranes to degrade oxida-
tively modi¢ed membrane proteins. In order to elu-
cidate the function of the 80 kDa serine protease in
erythrocyte cytosol and membranes, puri¢cation of
the protease from erythrocyte cytosol is now under
investigation.
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